BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gobert AP, Boutaud O, Asim M, Zagol-Ikapitte IA, Delgado AG, Latour YL, Finley JL, Singh K, Verriere TG, Allaman MM, Barry DP, McNamara KM, Sierra JC, Amarnath V, Tantawy MN, Bimczok D, Piazuelo MB, Washington MK, Zhao S, Coburn LA, Wilson KT. Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis. Gastroenterology 2021;160:1256-1268.e9. [PMID: 33189701 DOI: 10.1053/j.gastro.2020.11.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Rathmacher JA, Fuller JC Jr, Abumrad NN, Flynn CR. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans. Inflammation 2023;:1-10. [PMID: 36935449 DOI: 10.1007/s10753-023-01801-w] [Reference Citation Analysis]
2 Gobert AP, Asim M, Smith TM, Williams KJ, Barry DP, Allaman MM, McNamara KM, Hawkins CV, Delgado AG, Blanca Piazuelo M, Rathmacher JA, Wilson KT. The nutraceutical electrophile scavenger 2-hydroxybenzylamine (2-HOBA) attenuates gastric cancer development caused by Helicobacter pylori. Biomed Pharmacother 2023;158:114092. [PMID: 36493697 DOI: 10.1016/j.biopha.2022.114092] [Reference Citation Analysis]
3 Amalia R, Panenggak NSR, Doohan D, Rezkitha YAA, Waskito LA, Syam AF, Lubis M, Yamaoka Y, Miftahussurur M. A comprehensive evaluation of an animal model for Helicobacter pylori-associated stomach cancer: Fact and controversy. Helicobacter 2023;28:e12943. [PMID: 36627714 DOI: 10.1111/hel.12943] [Reference Citation Analysis]
4 Caspa Gokulan R, Paulrasu K, Azfar J, El-Rifai W, Que J, Boutaud OG, Ban Y, Gao Z, Buitrago MG, Dikalov SI, Zaika AI. Protein adduction causes non-mutational inhibition of p53 tumor suppressor. Cell Rep 2023;42:112024. [PMID: 36848235 DOI: 10.1016/j.celrep.2023.112024] [Reference Citation Analysis]
5 Zhong J, Yang HC, Shelton EL, Matsusaka T, Clark AJ, Yermalitsky V, Mashhadi Z, May-Zhang LS, Linton MF, Fogo AB, Kirabo A, Davies SS, Kon V. Dicarbonyl-modified lipoproteins contribute to proteinuric kidney injury. JCI Insight 2022;7. [PMID: 36125905 DOI: 10.1172/jci.insight.161878] [Reference Citation Analysis]
6 Zhu Y, Sun T, Zhang L, Fei F, Bao Y, Gao Z. Delineating Molecular Subtypes through Gene Set Variation Analysis Confers Therapeutic and Prognostic Capability in Gastric Cancer. Can J Gastroenterol Hepatol 2022;2022:5415758. [PMID: 35875363 DOI: 10.1155/2022/5415758] [Reference Citation Analysis]
7 Kon V, Shelton EL, Pitzer A, Yang HC, Kirabo A. Inflammation, Lymphatics, and Cardiovascular Disease: Amplification by Chronic Kidney Disease. Curr Hypertens Rep 2022. [PMID: 35727522 DOI: 10.1007/s11906-022-01206-4] [Reference Citation Analysis]
8 Ansari S, Yamaoka Y. Animal Models and Helicobacter pylori Infection. J Clin Med 2022;11:3141. [PMID: 35683528 DOI: 10.3390/jcm11113141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Xu W, Li B, Xu M, Yang T, Hao X. Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Biomed Pharmacother 2021;146:112542. [PMID: 34929576 DOI: 10.1016/j.biopha.2021.112542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Zhong J, Yang HC, Yermalitsky V, Shelton EL, Otsuka T, Wiese CB, May-Zhang LS, Banan B, Abumrad N, Huang J, Cavnar AB, Kirabo A, Yancey PG, Fogo AB, Vickers KC, Linton MF, Davies SS, Kon V. Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins. Kidney Int 2021;100:585-96. [PMID: 34102217 DOI: 10.1016/j.kint.2021.05.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]